Developing Highly Signaling-Pathway Selective Molecules Using Mebias’ 19Fluid Platform

Time: 2:30 pm
day: Day One

Details:

  • 19F NMR of native GPCRs in solution
  • Conformation driven drug discovery to determine pathway selectivity
  • Integrating pathway selectivity into drug discovery

Speakers: